Review explores aging reprogramming mechanisms in diminished ovarian reserve, highlighting novel therapeutic targets to restore female reproductive capacity.
Diminished Ovarian Reserve (DOR) is a significant manifestation of female reproductive aging that profoundly impacts fertility and quality of life. In recent years, the emergence of aging reprogramming technologies has provided new insights into the mechanisms underlying DOR and potential therapeutic approaches. This review synthesizes current knowledge on the role of aging reprogramming in DOR, focusing on key molecular events such as telomere shortening, mitochondrial dysfunction, and epigenetic alterations. Furthermore, we summarize clinical diagnostic criteria and emerging biomarkers for DOR, while exploring the limitations of existing treatment strategies and the potential interventions based on aging reprogramming. By addressing these issues, this review aims to highlight the interplay between aging processes and ovarian function, paving the way for innovative therapeutic avenues to improve reproductive health in women experiencing DOR.
No takes yet. Share an insight, caveat, or question.
Lang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: